GlaxoSmithKline CR`s Capital Expenditures (As % of Sales) reached 0.077 % in 2017. This is 66.8 % less than in the previous year.
Buy Capital Expenditures (As % of Sales) data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | ... | 0.474 | 0.240 | 0.245 | 0.085 | 0.115 | |||||||
| Bayer Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||||||
| Merck Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Novartis Czech Republic | % | 0.077 | 0.440 | 0.497 | 0.327 | 0.771 | |||||||||||||
| Pfizer Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Roche Czech Republic | % | ... | ... | ... | 1.55 | 3.38 | 2.90 | 3.02 | 2.16 | ... | |||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 0.144 | 0.188 | 0.049 | -0.020 | 0.042 | |||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0.354 | 0.912 | 1.24 | 0.676 | ||
| Walmark | % | ... | ... | ... | 3.35 | 1.87 | 12.7 | 3.29 | 16.0 |
Helgi Library 
